Imperial College London, London, UK.
AIDS. 2010 Mar 13;24(5):729-35. doi: 10.1097/QAD.0b013e32833433fe.
It has been suggested that a new strategy for HIV prevention, 'Universal Test and Treat', whereby everyone is tested for HIV once a year and treated immediately with antiretroviral therapy (ART) if they are infected, could 'eliminate' the epidemic and reduce ART costs in the long term.
We investigated the impact of test-and-treat interventions under a variety of assumptions about the epidemic using a deterministic mathematical model.
Our model shows that such an intervention can substantially reduce HIV transmission, but that impact depends crucially on the epidemiological context; in some situations, less aggressive interventions achieve the same results, whereas in others, the proposed intervention reduces HIV by much less. It follows that testing every year and treating immediately is not necessarily the most cost-efficient strategy. We also show that a test-and-treat intervention that does not reach full implementation or coverage could, perversely, increase long-term ART costs.
Interventions that prevent new infections through ART scale-up may hold substantial promise. However, as plans move forward, careful consideration should be given to the nature of the epidemic and the potential for perverse outcomes.
有人提出,一种新的艾滋病毒预防策略“普遍检测和治疗”,即每年对所有人进行一次艾滋病毒检测,如果感染了艾滋病毒,立即用抗逆转录病毒疗法(ART)进行治疗,可能会“消除”艾滋病流行,并从长期来看降低 ART 成本。
我们使用确定性数学模型,根据对艾滋病流行的各种假设,研究了检测和治疗干预的影响。
我们的模型表明,这种干预措施可以大大减少艾滋病毒的传播,但影响取决于流行病学情况;在某些情况下,不那么激进的干预措施可以达到相同的效果,而在其他情况下,所提议的干预措施减少的艾滋病毒要少得多。因此,每年进行检测并立即治疗不一定是最具成本效益的策略。我们还表明,一项未完全实施或覆盖的检测和治疗干预措施可能会适得其反,增加长期的 ART 成本。
通过扩大抗逆转录病毒疗法来预防新感染的干预措施可能具有很大的前景。然而,随着计划的推进,应仔细考虑疫情的性质和可能出现的不良后果。